Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients
The Leeds sleep evaluation questionnaire (LSEQ) is a standardized self‐reporting instrument comprising ten 100 mm visual analogue scales that pertain to the ease of getting to sleep (GTS), quality of sleep (QOS), ease of awakening from sleep (AFS) and alertness and behaviour following wakefulness (B...
Gespeichert in:
| Veröffentlicht in: | Human psychopharmacology 2003-12, Vol.18 (8), p.603-610 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 610 |
|---|---|
| container_issue | 8 |
| container_start_page | 603 |
| container_title | Human psychopharmacology |
| container_volume | 18 |
| creator | Tarrasch, Ricardo Laudon, Moshe Zisapel, Nava |
| description | The Leeds sleep evaluation questionnaire (LSEQ) is a standardized self‐reporting instrument comprising ten 100 mm visual analogue scales that pertain to the ease of getting to sleep (GTS), quality of sleep (QOS), ease of awakening from sleep (AFS) and alertness and behaviour following wakefulness (BFW). Although the LSEQ has been used in a variety of populations, published psychometric data on insomnia patients are limited.
The LSEQ reliability and construct validity was evaluated in 396 French insomnia patients aged 55 years and over, who were treated with placebo (2 weeks) and melatonin (3 weeks). The results supported LSEQ internal consistency, reliability and construct validity with minor differences from those of the original English version. Then the internal consistency of the LSEQ was evaluated in 257 insomnia patients (age 20–80 years) in France and Israel who, following a 1 week placebo baseline, were randomized to placebo or melatonin treatment for 3 weeks. Cronbach's α and Pearson's r correlation coefficients for placebo and drug treatment conditions (p |
| doi_str_mv | 10.1002/hup.534 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71484238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71484238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4294-59085bf13277d58ed0c5bb058b4f3e4be7ba83156e89a02ba140eda105d0c113</originalsourceid><addsrcrecordid>eNqF0FFr1TAUB_Agirub4idQ-qQO6TxpkiZ9dJe5O7iow4m-haQ93Y3mtjVpnfv2y10v-iRCIIHz40_On5BnFE4oQPF2Mw0ngvEHZEGhqnIKUj4kC1BK5GVRFAfkMMbvAGkG1WNyQHlZlUCrBTHL0MeY15Mfp2B89st415jR9V3Wt9m4wWyN2MQsesQhwzSe5unPCePu0RkXMHu9_nx2eZy5Lp3YbztnsiE57Mb4hDxqjY_4dH8fkav3Z1fLVb7-eH6xfLfOa15UPBcVKGFbygopG6GwgVpYC0JZ3jLkFqU1ilFRoqoMFNZQDtgYCiJJStkReTnHDqG__5veulij96bDfopaUq54wdR_YQFKlgx4gq9mWO8qCtjqIbitCbeagt61rlPrOrWe5It95GS32Px1-5oTeDODG-fx9l85evXl0xyXz9rFEX__0Sb80KVkUuivH871pVCn306XK71b_fneXze1ts56118HM2xcrRlIdgdraqSD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20876304</pqid></control><display><type>article</type><title>Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Tarrasch, Ricardo ; Laudon, Moshe ; Zisapel, Nava</creator><creatorcontrib>Tarrasch, Ricardo ; Laudon, Moshe ; Zisapel, Nava</creatorcontrib><description>The Leeds sleep evaluation questionnaire (LSEQ) is a standardized self‐reporting instrument comprising ten 100 mm visual analogue scales that pertain to the ease of getting to sleep (GTS), quality of sleep (QOS), ease of awakening from sleep (AFS) and alertness and behaviour following wakefulness (BFW). Although the LSEQ has been used in a variety of populations, published psychometric data on insomnia patients are limited.
The LSEQ reliability and construct validity was evaluated in 396 French insomnia patients aged 55 years and over, who were treated with placebo (2 weeks) and melatonin (3 weeks). The results supported LSEQ internal consistency, reliability and construct validity with minor differences from those of the original English version. Then the internal consistency of the LSEQ was evaluated in 257 insomnia patients (age 20–80 years) in France and Israel who, following a 1 week placebo baseline, were randomized to placebo or melatonin treatment for 3 weeks. Cronbach's α and Pearson's r correlation coefficients for placebo and drug treatment conditions (p<0.001 for all) supported LSEQ internal consistency in different treatment and age groups and in different languages.
It is concluded that the consistency, reliability and validity of the four LSEQ domains allows them to be singled out as independent outcome variables in cross cultural sleep research and clinical practice in adult and elderly patients with insomnia. Copyright © 2003 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0885-6222</identifier><identifier>EISSN: 1099-1077</identifier><identifier>DOI: 10.1002/hup.534</identifier><identifier>PMID: 14696019</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Aged ; Aged, 80 and over ; Clinical Trials as Topic ; Cross-Cultural Comparison ; factor ; Female ; Humans ; Insomnia ; Language ; Leeds ; Male ; Melatonin - therapeutic use ; Middle Aged ; questionnaire ; Reproducibility of Results ; Sleep ; Sleep Initiation and Maintenance Disorders - diagnosis ; Sleep Initiation and Maintenance Disorders - drug therapy ; Surveys and Questionnaires ; validation</subject><ispartof>Human psychopharmacology, 2003-12, Vol.18 (8), p.603-610</ispartof><rights>Copyright © 2003 John Wiley & Sons, Ltd.</rights><rights>Copyright 2003 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4294-59085bf13277d58ed0c5bb058b4f3e4be7ba83156e89a02ba140eda105d0c113</citedby><cites>FETCH-LOGICAL-c4294-59085bf13277d58ed0c5bb058b4f3e4be7ba83156e89a02ba140eda105d0c113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhup.534$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhup.534$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://igdc.huji.ac.il/home/Maagar/Details.aspx?AN=307$$D View record in IGDC$$Hfree_for_read</backlink><backlink>$$Uhttp://dx.doi.org/10.1002/hup.534$$D View full text (Access may be restricted)$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14696019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tarrasch, Ricardo</creatorcontrib><creatorcontrib>Laudon, Moshe</creatorcontrib><creatorcontrib>Zisapel, Nava</creatorcontrib><title>Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients</title><title>Human psychopharmacology</title><addtitle>Hum. Psychopharmacol. Clin. Exp</addtitle><description>The Leeds sleep evaluation questionnaire (LSEQ) is a standardized self‐reporting instrument comprising ten 100 mm visual analogue scales that pertain to the ease of getting to sleep (GTS), quality of sleep (QOS), ease of awakening from sleep (AFS) and alertness and behaviour following wakefulness (BFW). Although the LSEQ has been used in a variety of populations, published psychometric data on insomnia patients are limited.
The LSEQ reliability and construct validity was evaluated in 396 French insomnia patients aged 55 years and over, who were treated with placebo (2 weeks) and melatonin (3 weeks). The results supported LSEQ internal consistency, reliability and construct validity with minor differences from those of the original English version. Then the internal consistency of the LSEQ was evaluated in 257 insomnia patients (age 20–80 years) in France and Israel who, following a 1 week placebo baseline, were randomized to placebo or melatonin treatment for 3 weeks. Cronbach's α and Pearson's r correlation coefficients for placebo and drug treatment conditions (p<0.001 for all) supported LSEQ internal consistency in different treatment and age groups and in different languages.
It is concluded that the consistency, reliability and validity of the four LSEQ domains allows them to be singled out as independent outcome variables in cross cultural sleep research and clinical practice in adult and elderly patients with insomnia. Copyright © 2003 John Wiley & Sons, Ltd.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Clinical Trials as Topic</subject><subject>Cross-Cultural Comparison</subject><subject>factor</subject><subject>Female</subject><subject>Humans</subject><subject>Insomnia</subject><subject>Language</subject><subject>Leeds</subject><subject>Male</subject><subject>Melatonin - therapeutic use</subject><subject>Middle Aged</subject><subject>questionnaire</subject><subject>Reproducibility of Results</subject><subject>Sleep</subject><subject>Sleep Initiation and Maintenance Disorders - diagnosis</subject><subject>Sleep Initiation and Maintenance Disorders - drug therapy</subject><subject>Surveys and Questionnaires</subject><subject>validation</subject><issn>0885-6222</issn><issn>1099-1077</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0FFr1TAUB_Agirub4idQ-qQO6TxpkiZ9dJe5O7iow4m-haQ93Y3mtjVpnfv2y10v-iRCIIHz40_On5BnFE4oQPF2Mw0ngvEHZEGhqnIKUj4kC1BK5GVRFAfkMMbvAGkG1WNyQHlZlUCrBTHL0MeY15Mfp2B89st415jR9V3Wt9m4wWyN2MQsesQhwzSe5unPCePu0RkXMHu9_nx2eZy5Lp3YbztnsiE57Mb4hDxqjY_4dH8fkav3Z1fLVb7-eH6xfLfOa15UPBcVKGFbygopG6GwgVpYC0JZ3jLkFqU1ilFRoqoMFNZQDtgYCiJJStkReTnHDqG__5veulij96bDfopaUq54wdR_YQFKlgx4gq9mWO8qCtjqIbitCbeagt61rlPrOrWe5It95GS32Px1-5oTeDODG-fx9l85evXl0xyXz9rFEX__0Sb80KVkUuivH871pVCn306XK71b_fneXze1ts56118HM2xcrRlIdgdraqSD</recordid><startdate>200312</startdate><enddate>200312</enddate><creator>Tarrasch, Ricardo</creator><creator>Laudon, Moshe</creator><creator>Zisapel, Nava</creator><general>John Wiley & Sons, Ltd</general><scope>AGDVQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200312</creationdate><title>Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients</title><author>Tarrasch, Ricardo ; Laudon, Moshe ; Zisapel, Nava</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4294-59085bf13277d58ed0c5bb058b4f3e4be7ba83156e89a02ba140eda105d0c113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Clinical Trials as Topic</topic><topic>Cross-Cultural Comparison</topic><topic>factor</topic><topic>Female</topic><topic>Humans</topic><topic>Insomnia</topic><topic>Language</topic><topic>Leeds</topic><topic>Male</topic><topic>Melatonin - therapeutic use</topic><topic>Middle Aged</topic><topic>questionnaire</topic><topic>Reproducibility of Results</topic><topic>Sleep</topic><topic>Sleep Initiation and Maintenance Disorders - diagnosis</topic><topic>Sleep Initiation and Maintenance Disorders - drug therapy</topic><topic>Surveys and Questionnaires</topic><topic>validation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tarrasch, Ricardo</creatorcontrib><creatorcontrib>Laudon, Moshe</creatorcontrib><creatorcontrib>Zisapel, Nava</creatorcontrib><collection>IGDC Bibliographic Database - מאגר לחקר ההזדקנות</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tarrasch, Ricardo</au><au>Laudon, Moshe</au><au>Zisapel, Nava</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients</atitle><jtitle>Human psychopharmacology</jtitle><addtitle>Hum. Psychopharmacol. Clin. Exp</addtitle><date>2003-12</date><risdate>2003</risdate><volume>18</volume><issue>8</issue><spage>603</spage><epage>610</epage><pages>603-610</pages><issn>0885-6222</issn><eissn>1099-1077</eissn><abstract>The Leeds sleep evaluation questionnaire (LSEQ) is a standardized self‐reporting instrument comprising ten 100 mm visual analogue scales that pertain to the ease of getting to sleep (GTS), quality of sleep (QOS), ease of awakening from sleep (AFS) and alertness and behaviour following wakefulness (BFW). Although the LSEQ has been used in a variety of populations, published psychometric data on insomnia patients are limited.
The LSEQ reliability and construct validity was evaluated in 396 French insomnia patients aged 55 years and over, who were treated with placebo (2 weeks) and melatonin (3 weeks). The results supported LSEQ internal consistency, reliability and construct validity with minor differences from those of the original English version. Then the internal consistency of the LSEQ was evaluated in 257 insomnia patients (age 20–80 years) in France and Israel who, following a 1 week placebo baseline, were randomized to placebo or melatonin treatment for 3 weeks. Cronbach's α and Pearson's r correlation coefficients for placebo and drug treatment conditions (p<0.001 for all) supported LSEQ internal consistency in different treatment and age groups and in different languages.
It is concluded that the consistency, reliability and validity of the four LSEQ domains allows them to be singled out as independent outcome variables in cross cultural sleep research and clinical practice in adult and elderly patients with insomnia. Copyright © 2003 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>14696019</pmid><doi>10.1002/hup.534</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-6222 |
| ispartof | Human psychopharmacology, 2003-12, Vol.18 (8), p.603-610 |
| issn | 0885-6222 1099-1077 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71484238 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Aged Aged, 80 and over Clinical Trials as Topic Cross-Cultural Comparison factor Female Humans Insomnia Language Leeds Male Melatonin - therapeutic use Middle Aged questionnaire Reproducibility of Results Sleep Sleep Initiation and Maintenance Disorders - diagnosis Sleep Initiation and Maintenance Disorders - drug therapy Surveys and Questionnaires validation |
| title | Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T13%3A19%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cross-cultural%20validation%20of%20the%20Leeds%20sleep%20evaluation%20questionnaire%20(LSEQ)%20in%20insomnia%20patients&rft.jtitle=Human%20psychopharmacology&rft.au=Tarrasch,%20Ricardo&rft.date=2003-12&rft.volume=18&rft.issue=8&rft.spage=603&rft.epage=610&rft.pages=603-610&rft.issn=0885-6222&rft.eissn=1099-1077&rft_id=info:doi/10.1002/hup.534&rft_dat=%3Cproquest_cross%3E71484238%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20876304&rft_id=info:pmid/14696019&rfr_iscdi=true |